Cassava Sciences, Inc.
(NASDAQ : SAVA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
CTLTCatalent, Inc. 1.58%85.442.1%$249.25m
SAVACassava Sciences, Inc. 4.03%11.610.0%$223.98m
HZNPHorizon Therapeutics Plc -1.10%78.795.8%$173.45m
JAZZJazz Pharmaceuticals Plc -1.56%139.292.4%$169.45m
MRNSMarinus Pharmaceuticals, Inc. 3.57%11.667.8%$134.12m
CORTCorcept Therapeutics, Inc. 1.79%17.655.5%$130.51m
VRXValeant Pharmaceuticals International, Inc. -1.87%14.9914.1%$88.20m
MYOKMyoKardia, Inc. 0.54%134.621.8%$63.66m
BHCBausch Health Cos., Inc. -2.00%14.970.0%$60.91m
AMRNAmarin Corp. Plc -1.63%3.941.5%$59.01m
ARGXargenx SE 2.21%261.000.0%$57.14m
SAGESAGE Therapeutics, Inc. 0.07%59.938.6%$45.81m
GWPHGW Pharmaceuticals Plc -2.01%97.506.2%$39.34m
AXSMAxsome Therapeutics, Inc. -5.78%72.041.9%$37.73m
PRGOPerrigo Co. Plc -0.09%45.596.8%$37.19m

Company Profile

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.